Home › Biotechnology

Biotechnology Market Research Reports & Consulting

Developments in the field of biotechnology have been categorized into three ‘waves’ or stages. In the first stage or the ‘green wave’, the industry was dominated by the agricultural applications of biotechnology. This was followed by medical applications in the ‘red wave’, and industrial applications in the ‘white wave’ wave’ of biotechnology. In red biotechnology, genetic engineering techniques are used to develop powerful new therapeutics for disease prevention, management, and cure. Biotechnology instrumentation finds applications in chemotherapy, microarray technology, immunoassay, electrophoresis, and mass spectrometry. Biotechnology tools have given rise to various interdisciplinary fields such as bioinformatics and pharmaco-genomics; and have revolutionized the fields of drug delivery, drug discovery, and personalized medicine. The reports in this section study the technology markets within the new and emerging fields of genomics, proteomics, bioinformatics, biomarkers, biomaterials, and biosimilars.

Market Reports

Title	Published	Price
Biomarkers Market (Discovery Technologies, Applications & Indications) – Global Trends, Opportunities & Forecasts (2011 – 2020) A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic response to a therapeutic intervention. Biomarkers are classified in different ways based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of developing drugs and rise in the failure rate for drugs in phase II and III clinical trials, biomarkers are being employed on large scale by pharmaceutical companies to overcome these challenges. Also the advent of personalized medicine and companion diagnostics is witnessing a strong presence of use of biomarkers and holds to be a big opportunity for the overall biomarker market.	January 2012	$ 4650
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015) The report analyzes the various product segments under the broader biochips market, including lab chips, DNA chips etc. Market analysis includes over 100 market data tables that examine the biochips industry by products and geographies. The report has also profiles the key players and the competitive landscape in detail.	August 2011	$ 4650
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015) The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.	May 2011	$ 4650
Brazil Biomaterials Market (2010-2015) Brazil Biomaterials Market is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.	May 2011	$ 4650
Global Biomaterials Market (2010-2015) Global biomaterials market is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market.	May 2011	$ 4650
Top & Emerging Biofuels Market by Technology, Feedstocks, Regulations, Pricing & Commercialization Trends & Forecasts (2011 – 2016) Increasing demand of electricity and environmental concerns has put the pressure on countries to increase the focus on renewable energy. Governments support in terms of favorable policies and incentives, and advantages over other renewable energies are continuously increasing the production capacity of biofuels worldwide.	April 2011	$ 4650
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016) SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.	March 2011	$ 4650
Top 10 Drug Delivery Technologies Market (2010 - 2015) This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.	February 2011	$ 4650
Global Injectable Drug Delivery Market (2010-2015) Globally, injectable medications form the second most preferred class of drugs, with oral route of administration leading the global pharma market. Injectable drug delivery devices have evolved from traditional needles and syringes to recently developed needle-free injectors. The market has evidenced a shifting trend from administration of injections in clinician settings to home care settings, which has resulted in increasing the focus of industry players towards the development of user friendly and patient compliant devices.	February 2011	$ 4650
Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.	February 2011	$ 4650
Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015) The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.	November 2010	$ 4650
Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) Bioinformatics plays an important role in developing new tools that can tackle large amounts of voluminous data. Life science and pharmaceutical companies are thus looking towards bioinformatics to use it as a primary means for data handling, especially for the structured analysis of biological data.	July 2010	$ 4650
Global Stem Cell and Advanced Technologies Market This report reviews the current technologies in stem cell research and records the advances made in the development of these technologies and tools. The report gives a 360° view of the stem cell research market through its exhaustive market data on geographies, key players and technologies. Key players are profiled along with an analysis of their market strategies.	November 2009	$ 4650
Biosimilars (2009 - 2014) Biosimilars report will provide indepth market assessment, market estimates and forecast, competitive landscape for the series of biosimilars- Erythropoeitins, Granulocyte Colony Stimulating Factors, Market, HGH, Insulin and Analogs, Interferons. Report code- LS00110	September 2009	$ 4650
Electrophoresis Market (2011-2016) Electrophoresis is known as one of the most frequently used separation and analysis technologies in life science laboratories. The electrophoresis market is segmented in to two major segments gel electrophoresis (GE) and capillary electrophoresis (CE) of which gel electrophoresis accounts for the largest share of this market. This segment is expected to register a modest growth of around 4% primarily due to high installed base of these systems. Genomics, one of the primary applications is fueling the growth of this market.	March 2012	$ 4650
Biotechnology Instrumentation Market - A Global Scenario (2011 – 2016) Biotechnology equipment market is growing at a rapid rate due to the continuous requirement of biotechnology instruments in pharmaceutical and biotechnology industries support the rising trend towards biopharmaceuticals. Also the increase in number of biotechnology firms’ world wide, advances in life science research and technology innovations with human genome mapping and emergence of proteomics has enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity. All this factors are driving the biotechnology instrumentation market. Economic down turn, high cost of biopharmaceuticals and long gestation period are the factors restricting the market.	March 2012	$ 4650
Neuroscience Technologies and Global Market (2010 - 2015) Neuroscience research has come into prominence in the U.S. because of its military applications. Research has indicated that neuroscience can enhance the performance, learning and training of military personnel. This market research report takes an overview of the emerging technologies and tools in this area and also provides market data and profile of the key players.	March 2012	$ 4650
Chromatography Market (Gas Chromatography Market, Liquid Chromatography Market) (2011-2016) The global chromatography market has been segmented into liquid chromatography (LC) and gas chromatography (GC). LC is primarily utilized for commercial applications such as drug development and quality assessment of pharma and biopharma products. Widenning applications are the primary growth driver in this market. Apart from that, the greater efficiency levels offered by LC is another driving factor for this market. On the other hand GC is ruled by Chemicals & Pharmaceuticals end-use sector and forms a major growth driver in this market. Environmental and food safety issues in the developed countries is another major factor driving the market. Europe accounts for the largest share in the GC market, followed by the U.S. and Japan. APAC is expected to register the highest growth.	March 2012	$ 4650
Immunoassay Market (2011-2016) Immunoassays are most common lab test which help in identifying and quantifying blood components for a particular disease; most test focus on proteins in blood or other samples. Immunoassays are increasing used diagnosing cancer, disease research and immunology and have wide customer base in academic and the industrial arena. Shift in focus from genomics to proteomics is one of the driving factors in the market for immunoassays. Apart from this growth is also fueled by advances in technology which are faster, more accurate and cost effective such as ultrasensitive platforms, multiplex technologies, and novel biomarkers.	March 2012	$ 4650
Sequencers & Synthesizers Market: Global Forecasts (2011-2016) The global sequencers and synthesizers market comprises on DNA sequencers, amino acid sequencers and protein/peptide sequencers and synthesizers. The DNA sequencing market, the largest contributing segment is expected to have high growth of about 20% during the study period. Life Science, drug discovery & development account for the two largest applications market in the DNA sequencing market. Emerging applications for DNA sequencing include clinical diagnostics and personal genomics.	March 2012	$ 4650
Global Biopesticides Market (2010-2015): Shifting Trends in Agrochemical Industry Biopesticides are non toxic and naturally occurring substances that help to control pests. The usage of biopesticides is growing worldwide at an impressive rate of 20% as they are now considered a viable alternative for chemical pesticides. Increasing concerns about environment pollution and toxic residual effects of chemical pesticides are driving the demand for biopesticides.	March 2012	$ 4650
Protein Microarrays Market (2011-2016) A protein microarray is a platform for gathering proteins by immobilizing prospective binding partners on a firm plane, followed by recognition and detection of the bound protein. Protein microarrays help scientists study protein interactions and expressions for the development of new diagnostic and therapeutic applications. Expressional, functional, and reverse arrays are the three main types of protein microarrays. Protein Microarrays market is expected to register a growth rate of 19.9% between 2010 and 2015. This market is driven by the advances in the fields of genomics and proteomics and improvements in the field of recombinant proteins.	March 2012	$ 4650
Mass Spectrometry Market: Global Forecasts (2011-2016) The mass spectrometry market has evolved from basic research in the early 20th century to a host of applications consisting of pharmaceutical development, cancer research, petroleum refining & security and monitoring. Development of improved ionization sources increased the applicability of the instruments. Pharmaceuticals, proteomics, biomarker research form the largest market for Mass Spectrometry, however, environmental testing, petroleum refining, security and semiconductor & electronics segments also contribute largely to the market.	March 2012	$ 4650
Cardiovascular Therapy - Advanced Technologies And Global Market (2010 - 2015) The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined.	March 2012	$ 4650
Cardiac Monitoring - Advanced Technologies and Global Market (2010 - 2015) The report gives a detailed analysis of the emerging technologies in the cardiac monitoring industry. The market data tables analyze the market by technologies, by products and by geographies. The report examines the various advanced cardiac monitoring technologies and patents; and gives a comprehensive view of the market drivers, restrains and challenges.	March 2012	$ 4650
Lab-on-Chip (Microfluidics) Market (2011-2016) A lab-on-chip (LOC) device is a miniaturized laboratory on a credit card sized chip with a network of micro-channels, electrodes, sensors, and electronic circuits. These chips are usually made of polymer, glass, Silicon, plastic, and other materials. LOC has evolved from MEMS (Micro electro mechanical systems) devices and can replicate all the functions of its counterparts in performing several clinical diagnostics tests. The lab-on-chip market is a fast growing segment of the global biochip market as its wide applications have led to increased adoption in pharmaceutical, biotechnology companies, and other research laboratories. Furthermore, these chips are not limited to human applications but are very suitable for a variety of veterinary needs, food safety, and environmental testing in industrial as well as remote areas. Diagnostics represents the largest potential application market for lab-on-chips growing at a CAGR of 22.6%.	March 2012	$ 4650
Recombinant Therapies- Advanced Technologies And Global Market (2010 - 2015) The report tracks the market for new and emerging recombinant products, including interferons, erythropoietin, vaccines etc. It gives a detailed analysis of the key players in this market, as well as of the patents and trends in the designer therapeutics industry. Over a 100 market data tables profile the engineered products.	March 2012	$ 4650
Tissue Arrays Market (2011-2016) A tissue microarray is manufactured by taking tissue biopsies from conventional histological paraffin blocks and placing them onto an array slide. It is analyzed by fluorescence in situ hybridization, immunohistochemistry, and RNA in situ hybridization. Frozen arrays and FFPE arrays are the major segments of this market. These microarrays are primarily used for target validation by studying gene and protein expression in multiple tissue samples in the development of diagnostics and therapeutics. This tissue microarray market is expected to register a CAGR of 18.9% between 2010 and 2015.	March 2012	$ 4650
GPCR - Technologies and Applications (2010 - 2015) G-Protein Coupled Receptors (GPCRs) are at the hub of drug development activities and are one of the most heavily investigated drug targets in the pharmaceutical sector. This research report does a qualitative and quantitative analysis of the competitive landscape and the key players in the GPCR industry. It also provides market data on GPCR drugs, as well as the restraints and drivers faced by this industry.	March 2012	$ 4650
Tissue Generation technology Market The Global market for Tissue regeneration is soaring high with an influencing growth rate above 15% per year through 2013. In 2008, U.S accounted for more than 85% of the worldwide market. Also the markets of Europe, Japan and other countries are expected to evidence significant growth in coming future. As major companies are concentrating on cardiovascular, urologic, organ regeneration, wound care, orthopedic and neurologic segments, tissue regeneration market is expecting pool of promising opportunities to be tabbed.	March 2012	$ 4650
Agriculture Biotechnology Market The agriculture Biotechnology market is undergoing substantial structural changes in recent years. Factors contributing to such changes are increasingly vital for seed and chemical industries. The mergers & Acquisition in this industry are governing the pattern of growth in this industry as a requirement to cater consolidation of costs and increasing the capacity of this industry. Along with the adoption of more advanced traits regarding technology and encroachment in market of further countries, specifically in Asia, the market for Agriculture biotech is expected to continuously expand in coming future.	March 2012	$ 4650
Food Biotechnology Market As the biotechnology market is evidencing the development in emerging technologies, it will continuously affect food industry by lowering the costs, offering new products. Also continuous efforts by the market players to improve microbial processes by improving the quality and nutritional value, is making this market more lucrative. The innovation in the Food biotechnology sector is assisting in industrialization of production related to fermented foods. Still the public acceptance is the most critical factor to be dealt by the industry. In fact the future of food biotechnology worldwide depends on the way adopted by the scientists, government and the industry to communicate with consumers on safety and benefits of this technology. More than 85 % of enzyme market globally is driven by U.S, EU and Japan. Also some Asian countries such as South Korea, India, Taiwan, and China are speculated to contribute in growth of this market.	March 2012	$ 4650
Global RNAi Technology Market (2010 - 2015) The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.	March 2012	$ 4650
Cell Culture Market for Media, Sera and Reagents (2011-2016) The choice of cells depends on various technical and economic aspects. E. coli, Bacillus subtitlus, and yeast are the most preferred bacteria as they are easier to grow, independent, and have metabolic capabilities. On the other hand, animal cells are fragile, larger than microorganisms and difficult to grow. Another important driver is the development of vaccines; influenza vaccines have been previously developed with the help of egg-based technology. However, due its labor-intensive approach, this has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture.	April 2012	$ 4650
Next Generation Sequencing Technologies Market (2011-2016) Next Generation sequencing is the next generation of DNA Sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, Next Generation Sequencing will revolutionize the medical research in academic laboratories and biopharma, and the applied markets.	April 2012	$ 4650